CRH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CRH is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has shown strong financial growth and hedge funds are increasing their positions, the technical indicators and stock trend suggest limited short-term upside. Additionally, there are no significant positive catalysts or proprietary trading signals to support an immediate buy decision.
The MACD is positive but contracting, indicating a potential slowdown in momentum. RSI is neutral at 58.208, and moving averages are converging, showing no clear trend. The stock is trading near its pivot point of 111.953, with resistance at 118.313 and support at 105.593. Overall, the technical indicators suggest a neutral stance.
Hedge funds are significantly increasing their positions, with a 168.58% rise in buying activity over the last quarter. The company's Q4 financials showed strong YoY growth in revenue (+6.16%), net income (+45.80%), and EPS (+49.02%). Analysts from Wells Fargo and Morgan Stanley recently upgraded or maintained overweight ratings, citing valuation and improving sentiment.
The stock has a high chance of negative short-term movement (-0.29% next day, -2.65% next week, -3.45% next month). There is no recent congress trading data or significant insider buying activity. Pre-market and regular market price changes are negative, showing weak sentiment.
In Q4 2025, CRH reported strong financial performance with revenue increasing by 6.16% YoY to $9.42 billion, net income up 45.80% YoY to $1.025 billion, and EPS rising 49.02% YoY to 1.52. Gross margin remained stable at 35.64%, up slightly by 0.03% YoY.
Analysts are generally positive on CRH, with multiple firms maintaining or upgrading to overweight ratings. However, some price targets have been slightly lowered, reflecting cautious sentiment due to macro risks. The average price target remains significantly above the current price, indicating potential long-term upside.
